Science & Enterprise subscription

Follow us on Twitter

  • New post on Science and Enterprise: Editorial Posts Resume Tomorrow https://t.co/ZTVMsYlwg8 #Science #Business
    about 6 hours ago
  • As mobile phones, smart watches, and tablets play an increasingly key role in our daily lives, a new report shows m… https://t.co/HNOl3qa4oI
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Mobile Industry’s Economic Role https://t.co/aMBZtn0gkM #Science #Business
    about 2 days ago
  • FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug https://t.co/srCucGLuB5
    about 3 days ago
  • A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million i… https://t.co/gn4NSNTmBR
    about 3 days ago

Please share Science & Enterprise

Infographic – Trust Varies in Facial Recognition Use

Trust in Facial Recognition

Americans overall express at least some trust about facial recognition use by law enforcement, but less confidence when used by businesses or employers. . . . → Read More: Infographic – Trust Varies in Facial Recognition Use

Companies Call for Genome Editing Regulations

Crispr genome edits illustration

A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine. . . . → Read More: Companies Call for Genome Editing Regulations

FDA Okays Celiac Disease Engineered Microbe Trial

fresh bread

A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial

Trial Shows Two Drugs Can Treat Ebola Virus

Ebola virus

A clinical trial in the Congo shows two different therapies made with synthetic antibodies are better able to treat Ebola infections than two other drugs tested. . . . → Read More: Trial Shows Two Drugs Can Treat Ebola Virus

FDA Investigating Data Manipulation in Gene Therapy Approval

Magnify facts

The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease. . . . → Read More: FDA Investigating Data Manipulation in Gene Therapy Approval

Anti-Smoking Ads Not Reaching Most in U.S.

Lit cigarette

A nationwide survey shows a majority of American adults, including half of those who smoke, did not see court-ordered anti-smoking TV or newspaper advertisements. . . . → Read More: Anti-Smoking Ads Not Reaching Most in U.S.

Analysis – Most New Drugs Not Adding Patient Benefits

Tablet with charts

An analysis of drugs approved for use in Germany since 2011 shows no evidence most treatments provide new or added benefits to patients compared to standard care. . . . → Read More: Analysis – Most New Drugs Not Adding Patient Benefits

Infographic – Where Vaccine Distrust is Greatest

Chart: mistrust in vaccines

While much attention is focused on the current measles outbreak, distrust of vaccines apparently goes beyond this one disease. . . . → Read More: Infographic – Where Vaccine Distrust is Greatest

Repurposing an Anti-Inflammatory Drug to Treat a Life-Threatening Disease

Schistosome worm

Researchers successfully identified a common drug compound, a non-steroidal anti-inflammatory, that is active against all growing stages of the parasite that causes schistosomiasis. . . . → Read More: Repurposing an Anti-Inflammatory Drug to Treat a Life-Threatening Disease

FDA Clears Wearable App Device for Migraine

Nerivio Migra patch

The Food and Drug Administration authorized a wearable nerve-stimulation device controlled by a mobile app to treat acute migraine headaches. . . . → Read More: FDA Clears Wearable App Device for Migraine